NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
17/04/2026 09:00
NASDAQ TRADE HALT KLRA.O REASON NOT AVAILABLE AT 04:00 AM
Recent news on Kailera Therapeutics
See all newsKardigan surges in Nasdaq debut after upsized $400 million IPO (updated)
Brief: Kailera Therapeutics Says Phase 2 Ribupatide Oral Shows Up To 12.1% Mean Weight Loss At 26 Weeks
Advisory: Research alert on Kailera Therapeutics withdrawn
Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut (updated)
Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut